4//SEC Filing
ASELAGE STEVE 4
Accession 0001127602-24-018708
CIK 0000882796other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:20 PM ET
Size
7.6 KB
Accession
0001127602-24-018708
Insider Transaction Report
Form 4
ASELAGE STEVE
Director
Transactions
- Award
Common Stock
2024-06-12+6,820→ 70,159 total - Award
Automatic Stock Option Grant
2024-06-12+49,933→ 49,933 totalExercise: $6.30From: 2025-06-12Exp: 2034-06-12→ Common Stock (49,933 underlying)
Holdings
- 2,500(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
- [F2]Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001221599
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:20 PM ET
- Size
- 7.6 KB